GLP-1/GIP analogs: potential impact in the landscape of obesity pharmacotherapy: potential impact in the landscape of obesity pharmacotherapy

Ryan A Lafferty, Peter R Flatt, Nigel Irwin

Research output: Contribution to journal › Review article › peer-review

4 Citations (Scopus)

Fingerprint

Dive into the research topics of 'GLP-1/GIP analogs: potential impact in the landscape of obesity pharmacotherapy: potential impact in the landscape of obesity pharmacotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences